Question

A 52-year-old with HFrEF (EF 30%) on ARNI, β‑blocker, and MRA remains NYHA II. Which additional class should be initiated to reduce HF hospitalization and CV death regardless of diabetes?

Accepted Answer

SGLT2 inhibitor (e.g., dapagliflozin)

Answer

Ivabradine

Answer

Hydralazine alone

Answer

Isosorbide mononitrate alone

Answer

Verapamil

Practice question

A 52-year-old with HFrEF (EF 30%) on ARNI, β‑blocker, and MRA remains NYHA II. Which additional class should be initiated to reduce HF hospitalization and CV death regardless of diabetes?